Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

Mark Bounthavong, Javed Butler, Chantal M. Dolan, Jeffrey D. Dunn, Kathryn A. Fisher, Nina Oestreicher, Bertram Pitt, Paul J. Hauptman and David L. Veenstra ()
Additional contact information
Mark Bounthavong: University of Washington
Javed Butler: Stony Brook University
Chantal M. Dolan: CMD Consulting
Jeffrey D. Dunn: Magellan Rx
Kathryn A. Fisher: CMD Consulting
Nina Oestreicher: Relypsa, Inc., a Vifor Pharma Group Company
Bertram Pitt: University of Michigan School of Medicine
Paul J. Hauptman: Saint Louis University School of Medicine
David L. Veenstra: University of Washington

PharmacoEconomics, 2019, vol. 37, issue 8, No 10, 1071 pages

Abstract: Correction to Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-019-00809-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:37:y:2019:i:8:d:10.1007_s40273-019-00809-1

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-019-00809-1

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().